Lead clinical-stage program, OLN324, is a higher potency VEGF/Ang2 bispecific antibody in a fully-recruited head-to-head study versus faricimab in wet AMD and DME, with topline data expected Q1 2026 ...
Kickoff of the 2025 high school football is just two weeks away and a new class of players are poised to become rising stars in Section V. We need your help to predict the best football player in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback